ORBIMED CAPITAL LLC 13D and 13G filings for Milestone Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | ORBIMED CAPITAL LLC | 0 0.000% | -2,583,821 (Position Closed) | Filing |
| 2022-02-11 4:32 pm Purchase | 2021-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | ORBIMED CAPITAL LLC | 2,583,821 8.700% | 90,712 (+3.64%) | Filing |
| 2021-02-12 5:03 pm Purchase | 2020-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | ORBIMED CAPITAL LLC | 2,493,109 8.360% | 2,493,109 (New Position) | Filing |